Clinical Trial Update: Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating BiRd regimen with BCMA CAR T-cell therapy in newly diagnosed multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• BCMA CAR-T Cell Therapy
• BiRd regimen

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Multiple Myeloma | Phase 3 | Status: UNKNOWN